Items where authors include "Bansback, N."

Export as [feed] Atom [feed] RSS
Jump to: Article | Monograph
Number of items: 13.

Article

Bansback, N., Trenaman, L., Mulhern, B.J. et al. (6 more authors) (2022) Estimation of a Canadian preference-based scoring algorithm for the Veterans RAND 12-item Health Survey (VR-12): a population survey using a discrete choice experiment. CMAJ open, 10 (3). E589-E598. ISSN 2291-0026

Marten, O., Mulhern, B., Bansback, N. et al. (1 more author) (2020) Implausible states: prevalence of EQ-5D-5L states in the general population and its effect on health state valuation. Medical Decision Making, 40 (6). pp. 735-745. ISSN 0272-989X

Mulhern, B.J., Bansback, N., Norman, R. et al. (1 more author) (2020) Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Medical Care, 58 (6). pp. 566-573. ISSN 0025-7079

Tsuchiya, A. orcid.org/0000-0003-4245-5399, Bansback, N., Hole, A. et al. (1 more author) (2019) Manipulating the 5 dimensions of the EuroQol instrument: the effects on self-reporting actual health and valuing hypothetical health states. Medical Decision Making, 39 (4). pp. 380-392. ISSN 0272-989X

Mulhern, B., Bansback, N., Hole, A.R. et al. (1 more author) (2017) Using Discrete Choice Experiment with duration to model EQ-5D-5L health state preferences: Testing experimental design strategies. Medical Decision Making, 37 (3). pp. 285-297. ISSN 1552-681X

Bansback, N., Hole, A.R., Mulhern, B. et al. (1 more author) (2014) Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues. Social Science and Medicine, 114C. 38 - 48.

Mulhern, B., Bansback, N., Brazier, J. et al. (9 more authors) (2014) Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Health Technology Assessment, 18 (12). ISSN 1366-5278

Bansback, N., Tsuchiya, A. orcid.org/0000-0003-4245-5399, Brazier, J. orcid.org/0000-0001-8645-4780 et al. (1 more author) (2012) Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies. PLOS One, 7 (2). e31115. ISSN 1932-6203

Bansback, N., Brazier, J., Tsuchiya, A. et al. (1 more author) (2010) Using a discrete choice experiment to estimate societal health state utility values. HEDS Discussion Paper, 10/03.

Nixon, R.M., O'Hagan, A., Oakley, J.E. et al. (4 more authors) (2009) The rheumatoid arthritis drug development model: a case study in Bayesian clinical trial simulation. Pharmaceutical Statistics, 8 (4). pp. 371-389. ISSN 1539-1604

Monograph

Brennan, A., Bansback, N. and Nixon, R. (2006) Modelling the cost effectiveness of TNF-α inhibitors in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry. Discussion Paper. (Unpublished)

Ward, S., Morris, E., Bansback, N. et al. (4 more authors) (2001) A rapid and systematic review of the clinical effectiveness and cost effectiveness of gemcitabine for the treatment of pancreatic cancer. Technical Report. Core Research , Alton.

Lloyd Jones, M., Hummel, S., Bansback, N. et al. (1 more author) (2001) A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Technical Report. Core Research , Alton.

This list was generated on Sat Mar 23 05:52:19 2024 GMT.